A Study of Participants With Initially Unresectable Hepatocellular Carcinoma That is Treated With Atezolizumab and Bevacizumab Plus Transarterial Chemoembolization
Clinical trial NCT06503250 · COMPLETED
Trial details
- NCT number
- NCT06503250
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2024-07-19
- Primary completion
- 2024-11-27
- Enrollment
- 113
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.